News & Updates

Immunization with the non-live recombinant zoster vaccine (RZV) or live-attenuated zoster vaccine (ZVL) is associated with reductions in the risk of dementia relative to the 23-valent pneumococcal polysaccharide vaccine (PPSV23), according to a large observational study in adults aged ≥50 years.

Women who experience pre-eclampsia during pregnancy face a heightened risk of vascular dementia later in life, according to the results of a meta-analysis.

The risk of major ischaemic and haemorrhagic events in patients with a history of cancer and cryptogenic stroke appears to be similar between those on apixaban and those on aspirin, according to a post hoc analysis of the ARCADIA* trial.

Combined physiotherapy and cognitive behavioural therapy (CBT) help produce improvements in functional movement disorder (FMD) symptoms and the physical aspects of the patients’ quality of life, as shown in a study.

DREAMS START*, a nonpharmacological intervention, reduces sleep disturbances in people living with dementia at home, according to a recent study presented at AAIC 2024.

Adults suffering from persistent loneliness are likely to experience worse cognitive function and alterations in brain structure, suggests new evidence from the ongoing Whitehall II cohort study, presented at AAIC 2024.